CAS 1166393-85-6

PF 4618433

Description:

PF 4618433, identified by its CAS number 1166393-85-6, is a chemical compound that belongs to a class of substances known for their potential applications in various fields, including pharmaceuticals and materials science. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category often exhibit unique properties that make them suitable for targeted applications. Typically, they may possess specific functional groups that influence their reactivity and interactions with biological systems. Additionally, the compound may demonstrate particular stability under various conditions, which is crucial for its efficacy in practical applications. As with many chemical substances, safety data sheets and regulatory information should be consulted to understand the handling, storage, and potential hazards associated with PF 4618433. For detailed and specific information regarding its characteristics, including experimental data and applications, consulting scientific literature or databases is recommended.

Formula: C₂₄H₂₇N₇O₂

Synonyms:

• Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[3-[(3-pyridinyloxy)methyl]-1H-pyrazol-5-yl]-
• CS-2665
• PF 4618433
• PF4618433 @2,PF4618433 @3
• 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[5-(pyridin-3-yloxymethyl)-1H-pyrazol-3-yl]urea
• PF4618433 @3
• PF-4618433 >=95%
• PF 4618433; PF4618433

PF-4618433

CAS: 1166393-85-6

PF-4618433

Purity: ≥95%

Molecular weight: 445.52g/mol

Ref: 54-BUP21728

PF-4618433

CAS: 1166393-85-6

Ref: 7W-GW6826

PF4618433

CAS: 1166393-85-6

PF4618433 is a molecule that binds to the tyrosine kinase domain of β-catenin, which is a protein implicated in many cellular processes. PF4618433 inhibits β-catenin's binding to other proteins, including the albumin-binding domain of protocadherin 15 and the kinase domain of insulin receptor substrate 2. These interactions are important for the regulation of cell growth and differentiation. In vitro studies show that PF4618433 inhibits the proliferation and migration of ventricular myocytes. The inhibition may be due to its ability to prevent β-catenin from binding with other proteins, including cadherins and insulin receptors.
PF4618433 is currently being studied as a potential drug target for treatment of heart disease, osteoporosis, neonatal renal failure, and cancer.

Formula: C₂₄H₂₇N₇O₂

Purity: Min. 95%

Molecular weight: 445.52 g/mol

Ref: 3D-RWB39385

PF-4618433

CAS: 1166393-85-6

PF-4618433 is a selective PYK2 inhibitor with osteogenic activity.

Formula: C₂₄H₂₇N₇O₂

Purity: 99.95%

Color and Shape: Solid

Molecular weight: 445.52

Ref: TM-T22397